Mellitus
Kathy Welch comes to Mellitus from Danforth Advisors and has over 20 years’ experience at the Controller and CFO level. Ms. Welch is an accomplished accounting professional with extensive experience assisting companies as they meet the challenges of growth, transition and automation, while continually improving accounting control and financial reporting.
Ms. Welch is a Certified Public Accountant and graduated summa cum laude with a B.S. and B.A. from Bryant University.
This person is not in any teams
This person is not in any offices
Mellitus
Mellitus is developing a novel in vitro diagnostic test for the measurement of Glycated CD59 (GCD59) with potential clinical utility in screening, diagnosis and monitoring of diabetes, stratification of complications risk and as a clinical trial test for pharmaceutical development. Mellitus' lead product candidate is a test for Gestational Diabetes Mellitus (GDM).